HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

IL-17 Receptor A Maintains and Protects the Skin Barrier To Prevent Allergic Skin Inflammation.

Abstract
Atopic dermatitis (AD) is a common inflammatory skin disease affecting up to 20% of children and 3% of adults worldwide and is associated with dysregulation of the skin barrier. Although type 2 responses are implicated in AD, emerging evidence indicates a potential role for the IL-17A signaling axis in AD pathogenesis. In this study we show that in the filaggrin mutant mouse model of spontaneous AD, IL-17RA deficiency (Il17ra-/- ) resulted in severe exacerbation of skin inflammation. Interestingly, Il17ra-/- mice without the filaggrin mutation also developed spontaneous progressive skin inflammation with eosinophilia, as well as increased levels of thymic stromal lymphopoietin (TSLP) and IL-5 in the skin. Il17ra-/- mice have a defective skin barrier with altered filaggrin expression. The barrier dysregulation and spontaneous skin inflammation in Il17ra-/- mice was dependent on TSLP, but not the other alarmins IL-25 and IL-33. The associated skin inflammation was mediated by IL-5-expressing pathogenic effector Th2 cells and was independent of TCRγδ T cells and IL-22. An absence of IL-17RA in nonhematopoietic cells, but not in the hematopoietic cells, was required for the development of spontaneous skin inflammation. Skin microbiome dysbiosis developed in the absence of IL-17RA, with antibiotic intervention resulting in significant amelioration of skin inflammation and reductions in skin-infiltrating pathogenic effector Th2 cells and TSLP. This study describes a previously unappreciated protective role for IL-17RA signaling in regulation of the skin barrier and maintenance of skin immune homeostasis.
AuthorsAchilleas Floudas, Sean P Saunders, Tara Moran, Christian Schwartz, Emily Hams, Denise C Fitzgerald, James A Johnston, Graham S Ogg, Andrew N McKenzie, Patrick T Walsh, Padraic G Fallon
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 199 Issue 2 Pg. 707-717 (07 15 2017) ISSN: 1550-6606 [Electronic] United States
PMID28615416 (Publication Type: Journal Article)
CopyrightCopyright © 2017 by The American Association of Immunologists, Inc.
Chemical References
  • Cytokines
  • FLG protein, human
  • Filaggrin Proteins
  • Il17ra protein, mouse
  • Il33 protein, mouse
  • Interleukin-33
  • Interleukin-5
  • Interleukins
  • Intermediate Filament Proteins
  • Mydgf protein, mouse
  • Receptors, Antigen, T-Cell, gamma-delta
  • Receptors, Interleukin-17
  • interleukin-22
  • Thymic Stromal Lymphopoietin
  • TSLP protein, mouse
Topics
  • Animals
  • Cytokines (immunology)
  • Dermatitis, Atopic (immunology, pathology)
  • Disease Models, Animal
  • Dysbiosis
  • Eosinophilia (immunology)
  • Filaggrin Proteins
  • Gene Expression Regulation
  • Homeostasis
  • Interleukin-33 (immunology)
  • Interleukin-5 (genetics, immunology)
  • Interleukins (genetics, immunology)
  • Intermediate Filament Proteins (deficiency, genetics)
  • Mice
  • Microbiota
  • Mutation
  • Receptors, Antigen, T-Cell, gamma-delta (immunology)
  • Receptors, Interleukin-17 (deficiency, genetics, immunology, metabolism)
  • Signal Transduction
  • Skin (growth & development, immunology, microbiology, pathology)
  • Th2 Cells (immunology)
  • Thymic Stromal Lymphopoietin

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: